Hope for relapsed myeloma: Preclinical and clinical evidence for ruxolitinib’s efficacy

A new research perspective was published in Oncotarget’s Volume 15 on February 5, 2024, entitled, “Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma.”

Moderna reports $1.2bn net loss in Q1 2024

Moderna attributed the decline in revenues to the reduced sales of its Covid-19 vaccine. Credit: Tada Images / Shutterstock.com. Moderna experienced a substantial financial shift

May 3, 2024

New insights into dendritic cell biology could lead to improved cancer therapies

The cells of the immune system circulate mainly in the blood and migrate into the body’s tissues after an inflammation. Some types of immune cells,

July 17, 2023

Opinion | How to Provide Affirming Psychiatric Care to LGBTQ Teens in Transition

Emily Hutto is an Associate Video Producer & Editor for MedPage Today. She is based in Manhattan. In this video, Jeremy Faust, MD, editor-in-chief of

June 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.